DE60311779D1 - Steroidische chinole als antioxidantien-vorstufen - Google Patents

Steroidische chinole als antioxidantien-vorstufen

Info

Publication number
DE60311779D1
DE60311779D1 DE60311779T DE60311779T DE60311779D1 DE 60311779 D1 DE60311779 D1 DE 60311779D1 DE 60311779 T DE60311779 T DE 60311779T DE 60311779 T DE60311779 T DE 60311779T DE 60311779 D1 DE60311779 D1 DE 60311779D1
Authority
DE
Germany
Prior art keywords
chinole
steroid
estrogen
antioxidant preparations
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60311779T
Other languages
English (en)
Other versions
DE60311779T2 (de
Inventor
Laszlo Prokai
Katalin Prokai
James Simpkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
University of Florida Research Foundation Inc
Original Assignee
University of Florida
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida, University of Florida Research Foundation Inc filed Critical University of Florida
Publication of DE60311779D1 publication Critical patent/DE60311779D1/de
Application granted granted Critical
Publication of DE60311779T2 publication Critical patent/DE60311779T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
DE60311779T 2002-04-01 2003-04-01 Steroidale Chinole als Prodrugs von Antioxidantien Expired - Lifetime DE60311779T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36958902P 2002-04-01 2002-04-01
US369589P 2002-04-01
PCT/US2003/009983 WO2003084978A1 (en) 2002-04-01 2003-04-01 Steroidal quinols as prodrugs of antioxidants

Publications (2)

Publication Number Publication Date
DE60311779D1 true DE60311779D1 (de) 2007-03-29
DE60311779T2 DE60311779T2 (de) 2007-11-22

Family

ID=28791966

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60311779T Expired - Lifetime DE60311779T2 (de) 2002-04-01 2003-04-01 Steroidale Chinole als Prodrugs von Antioxidantien

Country Status (8)

Country Link
US (1) US7026306B2 (de)
EP (1) EP1490392B1 (de)
AT (1) ATE353907T1 (de)
AU (1) AU2003224816A1 (de)
DE (1) DE60311779T2 (de)
ES (1) ES2279946T3 (de)
PT (1) PT1490392E (de)
WO (1) WO2003084978A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2287184T3 (es) * 2000-11-03 2007-12-16 Washington University Estructuras aromaticas modificadas con sustituyentes hidroxi-, que tienen actividad citoprotectora.
US20070213310A1 (en) 2002-04-01 2007-09-13 Laszlo Prokai Prodrugs for Use as Ophthalmic Agents
US7186707B2 (en) 2002-04-01 2007-03-06 University Of Florida Prodrugs for use as ophthalmic agents
US7026306B2 (en) 2002-04-01 2006-04-11 University Of Florida Research Foundation, Inc. Steroidal quinols and their use for antioxidant therapy
US7300926B2 (en) * 2002-04-01 2007-11-27 University Of Florida Research Foundation, Inc. Steroidal quinols and their use for estrogen replacement therapy
AU2003297739A1 (en) * 2002-12-09 2004-08-30 University Of Florida Prodrugs for use a ophthalmic agents
US20070037848A1 (en) * 2003-04-03 2007-02-15 Masters Colin L Treatment of neurological conditions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2910486A (en) * 1957-12-20 1959-10-27 Searle & Co 10-hydroxyestra-1, 4-diene-3, 17-dione and acetate
US2950291A (en) * 1958-12-22 1960-08-23 Searle & Co 17-oxygenated estra-1, 3, 5(10)-triene-1, 4-diols, their esters, and a corresponding quinone
FR2644789B1 (fr) * 1989-03-22 1995-02-03 Roussel Uclaf Nouveaux steroides 19-nor, 3-ceto comportant une chaine en 17 aminosubstituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
US6197833B1 (en) 1995-07-24 2001-03-06 Apollo Biopharmaceutics, Inc. Neuroprotective effects of polycyclic phenolic compounds
US5554601A (en) 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
US5859001A (en) 1996-01-11 1999-01-12 University Of Florida Research Foundation, Inc. Neuroprotective effects of polycyclic phenolic compounds
US6319914B1 (en) 1993-11-05 2001-11-20 Apollo Biopharmaceuticals, Inc. Cytoprotective effect of polycyclic phenolic compounds
US5395831A (en) 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
JPH11513021A (ja) 1995-08-02 1999-11-09 カイロサイエンス・リミテッド キノロン類およびその医療上の使用
US7488723B2 (en) 2001-09-05 2009-02-10 Alcon, Inc. Use of non-feminizing estrogens as treatment for retinal vascular diseases
US20040214806A1 (en) 2002-09-03 2004-10-28 Iok-Hou Pang Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
WO2003047559A1 (en) 2001-12-05 2003-06-12 Mitokor, Inc. Use of polycyclic phenolic compounds for the treatment of opthalmic diseases
US7026306B2 (en) 2002-04-01 2006-04-11 University Of Florida Research Foundation, Inc. Steroidal quinols and their use for antioxidant therapy

Also Published As

Publication number Publication date
US20030229060A1 (en) 2003-12-11
PT1490392E (pt) 2007-04-30
ATE353907T1 (de) 2007-03-15
EP1490392B1 (de) 2007-02-14
WO2003084978A1 (en) 2003-10-16
EP1490392A1 (de) 2004-12-29
ES2279946T3 (es) 2007-09-01
AU2003224816A1 (en) 2003-10-20
DE60311779T2 (de) 2007-11-22
US7026306B2 (en) 2006-04-11

Similar Documents

Publication Publication Date Title
HN2006020928A (es) "composiciones de tanaproget que contienen etinil estradiol"
YU43002A (sh) Metod za hemoprevenciju kancera prostate
GEP20115213B (en) Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
SE0400346D0 (sv) Steroids for cancer treatment
IL216194A0 (en) Pharmaceutical compositions of a neuroactive steroid and uses thereof
PT680327E (pt) Utilizacoes terapeuticas e sistemas de distribuicao de desidroepiandrosterona
BR0113670A (pt) Composição farmacêutica e método para tratar hipogonadismo
MXPA05009985A (es) Ligandos de receptores de canabinoides.
BR0210028A (pt) Agentes antibacterianos
BRPI0400214A8 (pt) Composições e aplicações farmacêuticas para a obtenção confiável de níveis aceitáveis de testosterona no soro
PE20080995A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroeteres(18-metil-19-nor-20-espirox-4-en-3-onas), asi como preparaciones farmaceuticas que los contienen
DE60311779D1 (de) Steroidische chinole als antioxidantien-vorstufen
ES2185187T3 (es) Derivados no estrogenicos de estradiol con actividad antioxidante.
AU2003253506A1 (en) Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
RS90504A (en) C-17 spirolactonization and 6,7 oxidation of steroids
SG154323A1 (en) Estrogen replacement therapy
BR0214918A (pt) 6h-dibenzo[c,h]cromenos substituìdos como agentes estrogênicos
BR0111051A (pt) Produto farmacêutico e dose farmacêutica diária para administração a um paciente, regime de dose prover um efeito anti-androgênico e um efeito anti-estrogênico em um paciente, uso de um composto e de tamoxifeno ou de um sal ou solvato farmaceuticamente aceitável destes, e, método para prover um efeito anti-androgênico em um paciente
ES2152648T3 (es) Difenilestilbenos como profarmacos inhibidores de la cox-2.
WO2004091535A3 (en) Methods of administering estrogens and progestins
AR043013A1 (es) Composicion farmaceutica destinada al tratamiento de la endometriosis
PT1635843E (pt) Terapia de substituição hormonal e de depressão compreendendo dienogest
EA201000097A1 (ru) 8-бета-замещенные эстратриены в качестве селективно активных эстрогенов
BR0108411A (pt) Formulação contraceptiva masculina compreendendo noretisterona
DE60210283D1 (de) 2-substituierte 1,2,3,4-tetrahydrochinoline und derivate davon, zusammensetzungen und verfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition